These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30999681)

  • 21. Topical treatments for skin cancer.
    Cullen JK; Simmons JL; Parsons PG; Boyle GM
    Adv Drug Deliv Rev; 2020 Jan; 153():54-64. PubMed ID: 31705912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.
    Spugnini EP; Biroccio A; De Mori R; Scarsella M; D'Angelo C; Baldi A; Leonetti C
    J Transl Med; 2011 Jul; 9():125. PubMed ID: 21798045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
    Rass K; Reichrath J
    Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognising Skin Cancer in Primary Care.
    Jones OT; Ranmuthu CKI; Hall PN; Funston G; Walter FM
    Adv Ther; 2020 Jan; 37(1):603-616. PubMed ID: 31734824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solar ultraviolet exposure and mortality from skin tumors.
    Berwick M; Pestak C; Thomas N
    Adv Exp Med Biol; 2014; 810():342-58. PubMed ID: 25207375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.
    Feller L; Khammissa RAG; Kramer B; Altini M; Lemmer J
    Head Face Med; 2016 Feb; 12():11. PubMed ID: 26850723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic alterations in ultraviolet radiation-induced skin carcinogenesis: interaction of bioactive dietary components on epigenetic targets.
    Katiyar SK; Singh T; Prasad R; Sun Q; Vaid M
    Photochem Photobiol; 2012; 88(5):1066-74. PubMed ID: 22017262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation.
    Amaro-Ortiz A; Yan B; D'Orazio JA
    Molecules; 2014 May; 19(5):6202-19. PubMed ID: 24838074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.
    Benjamin CL; Melnikova VO; Ananthaswamy HN
    Adv Exp Med Biol; 2008; 624():265-82. PubMed ID: 18348463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathology of skin neoplasms of the head and neck.
    Kraft S; Granter SR
    Arch Pathol Lab Med; 2014 Jun; 138(6):759-87. PubMed ID: 24878016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ultraviolet A-induced DNA damage: role in skin cancer].
    Beani JC
    Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
    Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reaching first base in the treatment of metastatic melanoma.
    Eggermont AM
    J Clin Oncol; 2006 Oct; 24(29):4673-4. PubMed ID: 16966683
    [No Abstract]   [Full Text] [Related]  

  • 36. Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development.
    Melnikova VO; Pacifico A; Chimenti S; Peris K; Ananthaswamy HN
    Oncogene; 2005 Oct; 24(47):7055-63. PubMed ID: 16007135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress in malignant melanoma and non-melanoma skin cancer.
    Sander CS; Hamm F; Elsner P; Thiele JJ
    Br J Dermatol; 2003 May; 148(5):913-22. PubMed ID: 12786821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics.
    Lo JA; Fisher DE
    Science; 2014 Nov; 346(6212):945-9. PubMed ID: 25414302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing pathology with changing drugs: skin cancer.
    Karpova MB; Barysch MJ; Zipser MC; Schönewolf N; French LE; Dummer R
    Pathobiology; 2011; 78(2):61-75. PubMed ID: 21677470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation and expression of TP53 in malignant melanomas.
    Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
    Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.